We identified a striking number of synergistic interactions between inhibitors of the PI3K/AKT/mTOR signalling pathway, which has been shown to be essential to survival of BL cells5, and OTX015 within a subgroup of BL cell lines. The gene discussed is MTOR; the disease is Burkitt lymphoma.